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Abstract
L-amino acid oxidase (LAAO) occurs widely in snake venoms.  The enzyme is highly specific for L-amino acids, and generally
hydrophobic amino acids are the best substrates.  LAAO is a flavoprotein consisting of two identical subunits, each with a molecular
mass of approximately 60 kDa.  The purified enzymes are glycoproteins with 3-4% carbohydrate.  Deglycosylation of the enzyme did
not alter the enzymatic activity but appeared to alter its pharmacological activities.  The amino acid sequences of snake venom
LAAOs showed a high degree of homology.  X-ray structural analysis of LAAO revealed a dynamic active site and the presence of 3
domains: a FAD-binding domain, a substrate-binding domain and a helical domain.  LAAOs were reported to exhibit moderate lethal
toxicity.  Recent studies showed that LAAOs are multifunctional enzymes exhibiting edema-inducing, platelet aggregation inducing
or inhibiting, apoptotic inducing as well as anti-bacterial, anti-coagulant and anti-HIV effects.  These effects are mostly mediated by
the H2O2 liberated in the oxidation process but direct interactions between LAAO and the target cells may play an important role.
High resolution X-ray structure of the enzyme revealed the presence of a channel that would direct the H2O2 product to the exterior
surface of the protein, near the glycan moiety at Asn 172.  The glycan moiety was thought to be involved with LAAO-target cell
interaction.  This may explain the ability of LAAO to localize H2O2 to the targeted cells.  A better understanding of the
pharmacological actions of LAAOs will facilitate the application of snake venom LAAOs in the design of anti-cancer and anti-HIV
drugs as well as drugs for the treatment of infectious diseases caused by parasites such as leishmaniasis.
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Introduction
L-Amino acid oxidase (L-amino acid:O2 oxidoreductase,
E.C. 1.4.3.2.) is a flavoenzyme that catalyzes the oxidative
deamination of an L-amino acid to form the corresponding
α-ketoacid and ammonia: RCH(NH3+)COO- + O2 + H2O +
RCOCOO- + NH4+ +  H2O2
L-Amino acid oxidase (LAAO) occurs widely in nature
[1] and snake venoms are perhaps the richest sources of
the enzyme.  Snake venom LAAOs are generally very
active and have been used widely in preparation of
α-keto acids because of their chemo- and stereospecificity
[2, 3]. α-Keto acids of essential amino acids are useful
nutraceuticals as well as therapeutic agents for certain
diseases.  Recently, snake venom LAAO has become an
interesting object for biomedical studies because of its
antimicrobial, anti-HIV, anticoagulant, platelet
aggregation-inducing and inhibiting, apoptotic-inducing
as well as anti-cancer activities.  Snake venom LAAO is
recognized as a multifunctional protein with promising
biomedical application.  Several reviews on snake venom
L-amino acid oxidases have been published [1, 4-9].
LAAO Assay Methods
Many methods of LAAO assay are available [1].  The
O2 electrode technique has been widely used, particularly
in kinetic studies.  A commonly used spectrophotometric
method was described by Bergmeyer, which measured
the rate of oxidation by measuring the rate of formation
of color complex between the hydrogen peroxide produced
and o-dianisidine [10].  Based on the same principle, a
spectrophotometric microplate assay has been developed
suitable for processing large numbers of samples [11].
Occurrence in Snake Venoms
LAAO can be found in venoms from most genera [12].
The richest sources of LAAO are the crotalid venoms.
The enzyme usually constitutes 1-4% of the venom by
weight but in Calloselasma rhodostoma (Malayan pit viper)
it constitutes up to 30% by weight of the dried venom [8].
Venoms from mamba and sea snakes either contain no or
trace amount of L-amino acid oxidase activity.
Purification of Snake Venom LAAOs
Since 1990s, many authors have reported the
purification and characterization of LAAOs from various
snake venoms (Table 1).  In some snake venoms, the
enzymes present were in many isoforms.  Hayes and
Wellner, for example, reported that there were at least 18
isoforms of the LAAO in Crotalus adamanteus venom,
and that glycosylation contributes to the microheterogeneity
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for the enzyme [13].  However, microheterogeneity was
not observed for LAAOs isolated from most other venoms.
In general, it is relatively easy to obtain homogenous
LAAO from snake venom.  For example, the LAAO
from C. rhodostoma venom can be obtained using a
simple two-step procedure: Sephadex gel-filtration
chromatography followed by Mono-Q high performance
ion exchange chromatography (Figure 1) [14].
Table 1: Physiochemical Properties of Some Purified Venom L-Amino Acid Oxidases
Venom source Some physical properties Reference
Agkistrodon controtix laticinctus 120 kDa (dimer), 60 kDa, pI 4.4 Souza et al. [32]
A.halys blomhoffii 60 kDa, pI 4.9 Takatsuka et al. [22]
Bothrops alternatus 123 kDa (dimer), 66 kDa,  pI 5.37 Stabeli et al. [28]
B. moojeni 140 kDa (dimer), 69 kDa, pI 4.8 Tempone et al. [51]
B. piraja 66 kDa Izidora et al. [29]
Calloselasma rhodostoma 132 kDa (dimer), 66 kDa, pI 4.4, carbohydrate 4.4% Ponnudurai et al. [14]
Crotalus admanteus 58.7 kDa carbohydrate 3-4% Raibekas and Massey, [19]
C. atrox 100 kDa (dimer), 55 kDa, pI 6.0-6.5 Torii et al. [48]
C. dirissus cascavella 120 kDa (dimer), 68 kDa, pI 5.43 Toyama et al. [45]
Eristocophis macmahoni 58.7 kDa Ali et al. [44]
Naja naja kaouthia 112 kDa (dimer), 57.4 kDa, pI 8.12 Tan and Swaminathan [54]
Ophiophagus hannah 135 kDa (dimer), 65 kDa, pI 4.5, carbohydarate 3.8% Tan and Saifuddin [35], Li et al. [43]
Pseudechis australis 142 kDa (dimer), 56 kDa Stiles et al. [51]
V. berus berus 126 kDa (dimer), 55.7 kDa Samel et al. [33]
V. lebetina 140 kDa (dimer), 60.9 kDa Tonismagi et al. [34]
Trimeresurus flavoridis 55 kDa Abe et al. [55]
T. mucrosquamatus 140 kDa (dimer), 70 kDa, pI 5.6 Ueda et al. [56]
T. stejnegeri 120 kDa (dimer), 58 kDa, Zhang et al. [23]
Physical Properties of Snake Venom LAAOs
General physical properties
Snake venom LAAOs generally have molecular mass
ranging from 112 kDa to 140 kDa as determined by gel
filtration chromatography and 57-68 kDa by SDS-
polyacrylamide gel electrophoresis, indicating that the
enzymes are dimers and usually with identical subunits
(Table 1).  Snake venom LAAOs have a wide range of
isoelectric points, ranging from 4.4 to 8.12 [8].  LAAO is
a flavoprotein with two molecules of flavin coenzymes.
The flavins, which exhibit absorption maximum at 275,
390 and 462 nm, are responsible for the yellowish color
of the enzyme as well as for the venoms.  Most authors
reported that the flavin coenzymes are both FAD though
some earlier reports suggested FMN as the coenzymes
[8].
Snake venom LAAOs are stable at room temperature
and at 4°C [8].  Ophiophagus hannah LAAO, for example,
at pH 7.4, retained 100% and 80%, respectively, of activity
after incubating at 37°C for 5, and 14 days.  Many
LAAOs, however, are unstable at alkaline condition.
Some snake venom LAAOs have highly sensitive active
sites.  For example, C. adamanteus LAAO undergoes
reversible pH or temperature-dependent inactivation,
accompanied by structural changes in flavin binding site
though retaining its overall secondary structure [15].
Earlier, Curti et al. reported that C. adamanteus LAAO
was inactivated by storage at -5°C and -60°C, and by
freeze-drying [16].  Many other snake venom LAAOs
are also inactivated by freezing.  Generally, the inactivated
enzyme can be reactivated completely by heating at pH
5.  The inactivation was accompanied by shifts in
absorption spectrum and optical rotary dispersion
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spectrum, and reactivation reverses the spectra changes
completely.  The inactivation was believed to be due to a
limited conformational change of the enzyme structure,
presumably also in the vicinity of the flavin biding site
[17].  This has been substantiated by X-ray structural
studies.  Some snake venom LAAOs (for example,
LAAOs from O. hannah and C. rhodostoma), however,
are not inactivated by freezing [8].
Reconstitution of LAAO
As a result of the high sensitivity of many snake
venom LAAOs to their microenvironment, it was not
possible to prepare reconstitutable apoprotein, as
reconstitution with the FAD coenzyme often resulted in
an inactive protein, with a perturbed conformation of the
flavin binding site.  Raibekas and Massey reported near
complete activation of the reconstituted apoprotein and
the restoration of its native flavin binding site in the
presence of 50% glycerol [18].  Glycerol as a co-solvent
plays a special role in this restorative process by induction
of rearrangement in the protein structure.  The authors
suggested that hydrophobic effect appears to be the
dominating force in this in vitro-assisted restorative
process.
Cloning and Expression of Snake Venom LAAOs
Several snake venom LAAOs have been cloned and
sequenced [19-25].  The expression of LAAO’s from
several animal species has been attempted in various
expression hosts but the levels of expression were
generally rather low, presumably due to the toxic effects
of LAAO to the host cells.  Torii et al., however, reported
that LAAO from Crotalus atrox could be expressed in an
active form in mammalian cells [20].  Kommoju et al.
reported the successful expression of active recombinant
LAAO in the methylotropic yeast Pichia pastoris [24].
The catalytic properties and substrate specificity of the
recombinant LAAO are similar to those of the native
enzyme.
Chemical Structure of LAAOs
N-terminal sequences
The N-terminal amino acid sequences of many LAAOs
have been elucidated and they are highly similar, except
that from O. hannah. (Figure 2).  There is the presence of
a highly conserved Glu rich motif.  The structure of
LAAO from C. rhodostoma revealed that residues 5-25
constituted one part of the substrate-binding domain.  The
conserved amino acids may therefore play an important
role in the substrate binding.
Figure 1: Purification of C. rhodostoma LAAO. The LAAO
fraction obtained from Sephadex G-200 gel
filtration chromatography by the crude venom
(100mg; insert, top right) was injected into the
column equilibrated with 0.02 M Tris-HCl, pH
8.5, and a linear, 0.2 to 0.4 M sodium chloride
gradient was started 2 min after injection of the
sample. Flow rate was 1 ml/min. Peak 6 was the
purified LAAO. (----): Sodium chloride gradient.
Figure 2: N-terminal amino acid sequence of some snake venom L-amino acid oxidases. Residues in bold are the same in
most enzymes. X: uncertain.  Sequences are taken from the following references:  Ponnudurai et al. [14], Sakurai
et al. [46], Izidoro et al. [29] and Tonismagi et al. [34].
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Amino acid sequences
Raibekas and Massey reported the cDNA and deduced
amino acid sequence of   C. adamanteus venom LAAO
[18].  Analysis and search for protein similarity showed
that the enzyme possesses 37% homology with a protein
encoded by the mouse B cell interleukin 4-induced Fig 1
protein, the role of which is yet to be determined.  The
N-terminus of the protein contains a common fingerprint
or βαβ-fold for binding of the adenylate moiety of FAD
[9].  Takatsuka et al. reported that the full-length cDNA
sequence of Agkistrodon halys blomhoffii LAAO encodes
a putative a signal peptide with 18 amino acid residues
and a 486-residue subunit (Figure 3) [22].  Franca et al.
reported the cDNA sequences of LAAO from B. moojeni
and B. jararacussu venom [25], and phylogenetic analysis
showed sequence identities within the range 83-87% being
closely related to LAAO from A. h. blomhoffii [22] and
Trimeresurus stejnegeri venoms [23].
Figure 3: Deduced amino acid sequence of Agkistrodon halys blomhoffii L-amino acid oxidase.  Adapted from Takatsuka
et al. [25].
Structure of glycans
LAAO is a glycoprotein with 3-4% carbohydrate, and
it has been shown that glycosylation contributes to the
microheterogeneity reported for some LAAOs [13].
Glycosylation appears to be important for the secretion
and the solubility of the protein.  Removal of the glycan
moieties from C. rhodostoma LAAO leads to insoluble
proteins [26].  The glycan moieties also appear to play an
important role in the pharmacological actions of the
enzyme.  It has been suggested that LAAO docks to the
cell surface leading to the generation of high local
concentrations of hydrogen peroxide [27], which mediates
many pharmacological actions of LAAOs.  Deglycosylation
of the enzyme, however, did not alter the enzyme activity
[28, 29].
Geyer et al. reported on the glycosylation of LAAO
from C. rhodostoma [26].  Its glycosylation is remarkably
homogeneous with the major oligosaccharide accounting
for approximately 90% of the total sugar content.  The
glycan is identified as a bis-sialylated, biantennary, core-
fucosylated dodecasaccharide.  An interesting possibility
with regard to the homogeneity of the glycan moiety is
that it is a functional requirement connected with the
biological activities ascribed to LAAO.
Three-dimensional Structure of LAAOs
X-ray structure of C. rhodostoma LAAO
The X-ray structure of C. rhodostoma LAAO has
been elucidated and the topography of the enzyme most
closely resembles that of polyamine oxidase [30].  The
data indicate that it is functionally a dimer consisting of
two 55 kDa protomers.  Each protomer consists of 15
α-helices and 22 β-strands that fold into three well-
defined domains: FAD-binding domain, substrate-binding
domain and a helical domain.  The main structural feature
of the FAD-binding domain (consists of residues 35-64,
242-318 and 446-486) is a six-stranded β-pleated sheet
sandwiched between three α-helices and a four-stranded
β-pleated sheet.  The motif makes up the classical
nucleotide-binding fold seen in many FAD-binding
enzymes.  The substrate-binding domain is made up of
residues 5-25, 73-129, 233-236 and 323-420.  The helical
domain is made up of residues 130-230, and comprises
one side of a funnel-shaped entrance to the active site of
the enzyme.  The interface between the substrate-binding
and helical domains forms a 25A long funnel, which
provides access to the active site.  Comparison of the
LAAO with the structure of mammalian D-amino acid
oxidase reveals significant differences in their modes of
substrate entry.
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Moustafa et al. reported a high resolution (1.8A) X-
ray structure of C. rhodostoma LAAO with its substrate
L-phenylalanine [31].  The data revealed a dynamic active
site, as conformational changes were apparent for the
isoalloxazine ring.  There was a Y-shaped channel system,
extending from the external surface of the protein to the
active site.  The authors suggested that one portion of
this channel may serve as the entry path for O2 during
the oxidative half-reaction.  On the other hand, the second
region, which was separated from the proposed O2 channel
by the N terminus (residues 8-16) of the protein, may
play a role in H2O2 release.  Presumably, the channel
would direct the H2O2 product to the exterior surface of
the protein, near the glycan moiety at Asn 172, which
was thought to anchor the enzyme to the host cell.  This
channel location may explain the ability of the enzyme to
localize H2O2 to the targeted cell and thus induce the
apoptotic effect as well as other pharmacological activities.
The X-ray structure confirmed that the carbohydrate
moieties are linked to Asn 172 and Asn 361.  The authors
speculated that the disialylated oligosaccarides at Asn
172, which is located in the vicinity to the channel leading
to the active site of the enzyme, may bind to siglecs
(sialic acid-binding Ig superfamily lectins) of the target
cells via its sialylated glycan moiety, and may then result
in production of locally high concentration of H2O2 in or
near the binding interface.  This, in turn, could lead to
oxidative damage of the siglec or another adjacent cell
structural element.
Molecular modeling of B. jararacussu and B. moojeni
LAAOs
Molecular modeling experiments with overlapping of
B. jararacussu and B. moojeni LAAO models
demonstrated that these proteins are almost identical [25].
In addition, the overall fold of the two models is very
similar to that of LAAO from C. rhodostoma venom.
All the essential residues in C. rhodostoma LAAO are
conserved in the B. moojeni and B. jararacussu LAAO
models, demonstrating the putative functional similarity
between the models and the C. rhodostoma LAAO
structure.  It is possible that most snake venom LAAOs
have similar three-dimensional structure.
Enzymatic Properties of LAAOs
General enzymatic properties
LAAO required Mg2+ and was inhibited by Ca2+,
phosphate as well as p-chloromercuribenzoate.  Certain
amino acids stabilize the enzyme, while at high
concentration they become inhibitors.  The enzyme is
also competitively inhibited by various aliphatic and
aromatic acids and had a pH optimum of between 7 and
8.5 [8].  LAAO from different sources differ substantially
in their specific activity.  When L-leucine was used as
the substrate, at pH 8.5, the specific activities of the
enzymes isolated from C. rhodostoma, N. kaouthia and
O. hannah were 0.54, 4.59 and 20.9 µmole/min/mg,
respectively. Substrate inhibition occurs at high substrate
concentrations.
Substrate specificity
LAAO did not oxidize any D-amino acid and was
highly specific for the L-enantiomer of amino acids.
Effective oxidation of L-amino acid by the enzyme
requires the presence of a free primary α-amino group.
Many authors have investigated substrate specificity of
snake venom LAAO  [8].  Generally, the best substrates
are L-Leu, L-Met, L-Phe, L-Tyr and L-Tryp, whereas
L-Lys, L-Ser, L-Thr, L-Asp and L-Glu were generally
hydrolyzed slowly or not at all [14, 28, 29, 32-34].  One
exception is the LAAO from O. hannah, with which “
L-Lys is the best substrate [35].  It is interesting to note
that the N-terminal sequence of the O. hannah (king
cobra) enzyme is very different from the other snake
venom LAAOs.
Examination of the substrate specificity data of snake
venom LAAOs suggested the presence of an alkyl side
chain binding site which comprises at least four sub-
sites, each accommodating a methyl/methylene carbon.
O. hannah LAAO, on the other hand, appears to have an
additional amino binding sub-site.  Dixon and Kleppe
suggested also the presence of an alkyl-binding site which
can accommodate a chain of four carbons in D-amino
acids [36].
Mechanism of catalysis
The oxidation of L-amino acid by the enzyme proceeds
in two steps, forming α-imino acid as the intermediate
product as detected by the borohydride trapping
experiments [5].
During the reductive half-reaction, the α-hydrogen
atom of the amino group is abstracted by FAD, producing
the α-imino acid intermediate, which then reacts with
water to form the α-keto acid.  Two alternative
mechanisms have been proposed for the reductive half-
reaction: (1) the carbanion mechanism, in which the proton
is transferred, leaving a negative charge on the alpha
carbon atom, and (2) a hydride-transfer mechanism, in
which the hydrogen atom and the two electrons are
transferred simultaneously.  Recent data are consistent
with a direct hydride transfer mechanism [37].
According to data obtained from high resolution
X-ray structure of C. rhodostoma LAAO [31],
conformational changes of the key active site components
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His 223, Arg 322 and the FAD cofactor can be related to
the direct hydride transfer mechanism:  Induced by the
presence of the zwitterionic form of the substrate, His
223 alters its side chain conformations (Figure 4; from
His 223(A) to His 223(B)).  The α-amino group of the
substrate is then de-protonated by His 223, and the
Over the last 15 years, LAAOs have become an
interesting object for biomedical studies because of its
apoptotic, cytotoxic, platelet aggregation, anticoagulant
and other physiological effects.  These effects are thought
to be mediated by the chemically very reactive hydrogen
peroxide generated in the oxidation process, because H2O2
scavenger such as catalase neutralizes the effects.
Sometimes the toxic effects cannot be attributed to H2O2
liberated alone and direct interactions between LAAO
and the target cells may play an important role [23].
Edema-inducing and hemorrhagic activities
Several authors reported that venom LAAO was able
to induce extensive edema in the mouse paw, and some
with slight hemorrhages [9, 28, 29, 40].  Tan and Choy
reported that O. hannah LAAO exhibited strong edema-
inducing activity [41], and the enzyme elicited a ‘delayed-
type’ time course of edema formation, indicating that the
edema formation caused by LAAO was not mediated
through release of amines subsequent to mast cell
degradation, which usually elicited a ‘rapid’ type of edema
formation.  The edema-inducing activity of the enzyme
was not inhibited by diphenhydramine or dexamethasone.
Izidoro et al. suggested that edema formation is due to
activation of the inflammatory response by the H2O2
generated, as administration of glutathione to the mouse
paw inhibited the edema-inducing activity of the enzyme
[29].  The hemorrhagic effect of LAAO results from
complex effects, and may involve apoptosis of endothelial
and other vascular cells.
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substrate is then activated.  The lone pair of electrons
from amino nitrogen atom then moves to the α-carbon
atom, followed by hydride transfer to FAD to form the
imine.  The conserved water molecule at Lys 326 may
play a role in the reductive half reaction or may assist in
H2O2 formation from the flavin-hydroperoxy intermediate.
Figure 4: Reaction mechanism for the oxidation of L-phenylalanine by L-amino acid oxidase.  The substrate is shown in
thick bonds. Two conformations for His 223 are included as labeled (from Moustafa et al. [31]; with permission).
Immunological Properties of LAAOs
Snake venom LAAOs are antigenically similar but it
has been reported that antibodies to O. hannah LAAO
yielded indirect ELISA cross-reactions with neurotoxin,
hemorrhagin and phospholipase A2 isolated from the same
venom, implying that the LAAO shares common epitopes
even with unrelated proteins [38].  This was supported
by recent studies by Stabeli et al. [39].  They reported
that antibodies to homoserine lactone derivatives of the
undecapeptide IQRWSLDKYAM (Ile1-Hse11) excised from
B. moojeni LAAO cross-reacted with some serine
proteases, phospholipase A2 homologues and LAAOs from
venoms of snakes of genera Bothrops, Lachesis, Crotalus
and Micrurus.  It was hypothesized that the cross-reactivity
of the anti-Ile1-Hse11 antibodies to unrelated venom
proteins derives from their mechanism of antigen
recognition, whereby complementary is achieved through
reciprocal conformational adaptation of the reacting
molecules.
Pharmacological Activities of LAAOs
Several LAAOs from snake venoms were reported to
exhibit moderate lethal toxicity with i.v. LD50 of
approximately 5-9 µg/g in mouse. The LD50 of LAAO is
usually higher than that of the corresponding venom, and
hence the enzyme is not a major lethal component of the
venom, as the enzyme usually constitutes less than 5% of
the venom dry weight [40].
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Anticoagulant effects
Sakurai et al. reported that LAAO purified from A. h.
blomhoffii venom possesses anticoagulant activity [42].
The enzyme significantly delayed the onset and progress
of blood coagulation, prolonged the activated partial
thromboplastin time but had little effect on the
prothrombin time.  The results indicated that LAAO
interferes primarily with the intrinsic blood coagulation
pathway, and further studies by the authors indicated that
the anticoagulant effect of LAAO is due to its inhibitory
action on clotting factor IX.
Effects on platelet aggregation
Reports on the effects of snake venom LAAOs on
platelet aggregation seems to be contradictory.  Some
authors reported that LAAOs induce platelet aggregation,
whereas others reported that LAAOs have an inhibitory
action on platelet aggregation [9].  Catalase, a H2O2
scavenger, inhibited both platelet aggregation inducing
and inhibiting effects, indicating that both effects are due
primarily to the action of H2O2 produced by the enzyme
during the oxidation.
LAAOs from venoms of C. durissus cascavella, E.
macmahoni, B. alternatus, B. pirajai, O. hannah induce
platelet aggregation [28-29, 43-45].  Toyama et al.
reported that the platelet aggregation inducing activity
was inhibited by cyclooxygenase pathway inhibitors such
as aspirin and indomethacin, suggesting that the H2O2
liberated leads to activation of inflammatory enzymes
[45]. Du and Clemetson suggested that the H2O2
production promoted a rapid increase of thromboxane A2
synthesis and consequently the platelet aggregation [9].
On the other hand, LAAOs from A. h. blomhoffi, V.
lebetina and N. naja kaouthia dose-dependently inhibited
both agonist-induced platelet aggregation and shear-
induced platelet aggregation [22, 34, 46].  One mechanism
for platelet aggregation inhibition may be connected with
a reduced binding for ADP in platelet exposed to H2O2,
or the interference of the peroxide in the interaction
between activated platelet integrin GPIIb/IIIa and
fibrinogen [18, 33].
It is still not clear why some LAAOs induce and
others inhibit platelet aggregation.  Sakurai et al. suggested
that the controversies may be connected with differences
in the experimental procedure or preparation of blood
samples [46].  Other possibilities include the difference
in specific activity of the enzyme, or the involvement of
mechanisms other than H2O2 liberation that are present
only in certain LAAOs.  Takatsuka et al., for example,
suggested that only LAAOs with very high specific
activities would induce platelet aggregation as initiation
of aggregation requires relatively high peroxide
concentration (mM range) [22].  However, since LAAOs
generally liberate H2O2 in only micro-molar
concentrations, it has been further suggested that
presumably these enzymes bind to the platelet and is thus
able to generate high concentrations of H2O2 locally to
induce platelet aggregation.
Apoptosis-inducing effect
Apoptosis is the programmed cell death characterized
by a distinct pattern of cellular events, including cleavage
of nuclear DNA into fragments that produce a typical
nucleosomal DNA ladder in agarose gel.  Snake venom
is known to exhibit apoptosis-inducing effect. Suhr and
Kim [47] and Torii et al. [48] reported that the snake
venom component that induced apoptosis was an LAAO,
and that the LAAO induced apoptosis in human umbilical
vein endothelial, human promyelocytic leukemia HL-60,
human ovarian carcinoma A2789 and mouse endothelial
KN-3 cells.  Since then, many snake venom LAAOs
were reported to also exhibit apoptosis-inducing activity
[22, 29, 32-33, 49-50], and the apoptosis was usually
demonstrated by the DNA fragmentation gel pattern.  The
apoptosis-inducing activity was abolished by catalase and
other H2O2 scavengers, indicating that the H2O2 generated
by LAAO action plays an important role in the apoptosis.
Tempone et al. suggested that cells submitted to oxidative
stress induced by LAAO generated H2O2 that could
activate heat shock proteins and initiate cell membrane
disorganization, DNA fragmentation, apoptosis and
therefore cell death [51].  Sun et al. suggested that the
generated peroxide activates the transcription of such
factors as the nuclear factor B, the activator protein 1,
Fas/Apo-1 and p53 [49].
Suhr and Kim, however, demonstrated that LAAO-
induced apoptotic mechanism was clearly distinguishable
from the one stimulated directly by exogenous H2O2,
suggesting that the LAAO-induced apoptosis was not
solely triggered by the peroxide produced by the oxidation
[27].  Takatsuka et al. demonstrated that venom LAAOs
directly bind to cell surface thereby increasing the local
peroxide concentration [22].  On the other hand, Torii
et al. reported that the venom LAAO did not associate
with human embryonic kidney cells [20].  The cause of
these discrepancies is not clear.
Ande et al. [50] and Samel et al. [33], using Jurkat
and K562 (human chronic myeloid leukemia) cells,
respectively, reported that at low concentration LAAO
induced apoptosis, but caused necrosis of the cells at
higher concentrations. According to Ande et al. the factors
contributing to apoptosis are: (i) generation of toxic
intermediates from fetal calf serum and (ii) binding and
internalization of LAAO, which appears to be mediated
by the glycan moiety of the enzyme, as desialylation of
the enzyme reduces cytotoxicity [50].  D-Amino acid
oxidase, which lacks glycosylation, also triggers necrosis
by the H2O2 liberated, but it does not cause apoptosis.
Thus, just like its effect on platelet aggregation, induction
of cell death by LAAO also appears to involve both the
generation of H2O2 and the molecular interaction of the
8glycan moiety of the enzyme with structures at the cell
surface.
Antibacterial activity
Stiles et al. reported that two LAAOs from the venom
of Pseudechis australis (Mulga snake) have a powerful
antibacterial effect against Gram-positive and Gram-
negative bacteria [52].  Compared to tetracycline, the
in vitro antibacterial effects of the enzymes were 18-70
times more effective, on a molar basis.  Recently, many
authors reported LAAO from other snake venoms also
exhibited similar antibacterial activity [28-29, 34, 45].  It
is believed that the antibacterial effect of LAAO is also
due to the H2O2 liberated, as addition of catalase
completely suppressed the antibacterial activity.  Electron
microscopic studies suggested that the H2O2 generated in
the oxidation process induced bacterial membrane rupture
and then cell death [45].  Zhang et al. reported that the A.
halys LAAO was able to bind to the surfaces of bacteria
and generate high concentrations of H2O2 locally, which
enables the enzyme to inhibit bacterial growth at low
concentrations [53].  It is not clear whether this happens
to other snake venom LAAOs.
Leishmanicidal activity
Leishmaniasis includes a spectrum of human infectious
disease ranging from self-healing cutaneous ulceration to
a progressive and lethal visceral infection.  It is a disease
that probably affects 12 million people and is prevalent
in 88 nations throughout the world.  Tempone et al. [51]
and Toyama et al. [45] reported that snake venom LAAO
possesses strong leishmanicidal activity, as the H2O2
generated by the enzyme was a strong inducer of apoptosis
in promastigotes of Leishmania ssp. cells.  At present,
few drugs are available for treatment of leishmaniasis.
The understanding of the mode of action of LAAO upon
parasites may trigger the design of new drugs or
therapeutical approaches for leishmaniasis.  For example,
if one was able to target a H2O2 generator, (such as snake
venom LAAO) towards the parasitophorous vacuole, this
would represent a highly specific treatment not only for
leishmaniasis but also for other intracellular parasites.
Anti-HIV activity
Zhang et al. reported that LAAO isolated from
T. stejnegeri venom possesses antiviral activity [23].  The
enzyme exhibited dose-dependent inhibition on HIV-I
infection and replication at concentrations that showed
little effect on cell viability.  Under the same experimental
conditions, no anti-HIV-1 activity was observed by
exogeneous addition of H2O2.  Furthermore, the presence
of catalase causes a decrease in its antivirus activity but
resulted in an increase of its antiviral selectivity.  The
authors suggested that while liberated H2O2 is involved
in the anti-HIV-1 activity of the LAAO, the dosages of
H2O2 and relative molecular pathways mediating
suppression in virus infection and replication are
independent and/or different from those of causing cell
death.  Presumably, the mechanism of the anti-HIV-1
effect of LAAO involves specific binding of the enzyme
to cell membrane, which helps to generate high local
concentrations of H2O2 to trigger certain signal reactions
and activation of host cells, resulting in the inhibition of
HIV infection and/or replication.
Conclusion
Prior to the 1990s, studies of snake venom LAAO
dealt mainly with their enzymatic properties and industrial
applications.  In the past 15 years, there has been
considerable progress in the studies of the structure and
mechanism of the enzyme but the focus has shifted to the
investigations of the pharmacological actions of the
enzyme and its potential biotechnological and medical
applications.  Snake venom LAAOs are interesting
multifunctional enzymes exhibiting edema-inducing,
platelet aggregation inhibiting or inducing, apoptotic
inducing and anti-HIV-1 activities as well as
anticoagulation effect.  Their toxicological actions are
due mainly, but not entirely, to the H2O2 liberated during
the oxidation.  The exact mechanism of the toxicological
actions of snake venom LAAO awaits further studies.
Sun et al. suggested that LAAO may be applied clinically
in glioma therapy by cloning the cDNA of the enzyme
and transfect to the tumor cells of patients to induce the
apoptosis in the target tumor cells [49].  Many authors
have demonstrated the apoptotic effect of snake venom
LAAO on various malignant cells (eg, S180 tumor, human
breast, acute T cell leukemia, Erlich ascetic tumor cell
lines).  There is therefore great potential in the application
of LAAO in cancer therapy.  The understanding of the
LAAO mode of action upon parasites may also trigger
the design of new drugs or therapeutical approaches for
leishmaniasis as well as other intracellular parasites.  In
addition, investigation on the anti-HIV activity of LAAO
would also provide valuable information on the therapeutic
development of new generations of anti-HIV drugs.
Acknowledgement
This work was supported by a research grant Science
Fund 02-01-03-SF0153 from the Ministry of Science,
Technology and Innovation (MOSTI), Malaysia.
Snake venom L-amino acid oxidases
9Snake venom L-amino acid oxidases
References
1. Iwanaga S, Suzuki T. L-Amino acid oxidase. In: Lee CY
ed. Handbook of experimental   pharmacology. Berlin:
Springer. 1979; 52: 75-84.
2. Szwajcer E, Brodelius P, Mosbach K. Production of
α-keto acids. Part 2: Immobilized whole cells of
Providencia sp. PCM 1298 containing L-amino acid
oxidase. Enzyme Microb Technol 1982; 4: 409-413.
3. Findrik Z, Geueke B, Hummel W, Vasic-Racki D.
Modelling of L-DOPA enzymatic oxidation catalyzed by
L-amino acid oxidase from Crotalus adamanteus and
Rhodococcus opacus. Biochem Eng J 2006; 27: 275-286.
4. Meister A, Wellner D. Flavoprotein amino acid oxidases.
In: Boyer PD, Lardy H, Myrback K eds. The enzymes, 2nd
Ed.  New York: Academic Press 1963; Vol. VII: 609-648.
5. Bright DJ, Porter DJT. Flavoprotein oxidases. In: Boyer
PD ed. The enzymes 3rd Ed. New York: Academic Press
1975; Vol. XIIB: 421-505.
6. Tu AT. Venoms: Chemistry and molecular biology. New
York: John Wiley, 1977.
7. Curti B, Massey V, Zmudha M. Inactivation of snake
venom L-amino acid oxidase by freezing. J  Biol Chem
1968; 243: 2306-2314.
8. Tan NH. L-Amino acid oxidases and lactate dehydrogenases.
In: Bailey GS ed. Enzymes from snake venom. Fort Collins:
Alaken Inc. 1998; Chapter 19, 579-598.
9. Du XY, Clemetson KJ. Snake venom L-amino acid oxidase.
Toxicon 2002; 40: 659-665.
10. Bergmeyer HV. L-Amino acid oxidase. In: Methods in
enzymatic analysis. Weinheim: Verlag Chimie, GmbH 1983;
2: 149-150.
11. Kishimoto M, Takahashi T. A spetrophotometric microplate
assay for L-amino acid oxidase. Anal Biochem 2001; 298:
136-139.
12. Tan NH, Ponnudurai G. Biochemical characterization of
snake venoms. Gopalakrishnakone P, Tan CK eds. In:
Recent advances in toxinology research. Singapore:
National University of Singapore. 1992; 210-258.
13. Hayes MB, Wellner D. Microheterogeneity of L-amino
acid oxidase. J Biol Chem 1969; 244: 6636-6644.
14. Ponnudurai G, Chung MCM, Tan NH. Purification and
properties of the L-amino acid oxidase from Malayan pit
viper (Calloselasma rhodostoma) venom. Arch. Biochem.
Biophys 1994; 313: 373-378.
15. Coles CJ, Edmondson DE, Singer TP. Reversible
inactivation of L-amino acid oxidase: properties of the
three conformational forms. J Biol Chem 1977; 252: 8035-
8039.
16. Curti B, Ronchi S, Simonetta PM. D- and L-amino acid
oxidases. In: Mueller F ed. Chemistry and biochemistry of
flavoenzyme. Boca Roton, FL: CRC Press. 1992; 3: 69-
94.
17. Soltysik S, Byron CM, Einarsdottir GH, Stankovich MT.
The effects of reversible freezing inactivation and inhibitor
binding on redox properties of L-amino acid oxidase.
Biochim Biophys Acta 1987; 911: 201-208
18. Raibekas AA, Massey V.  Primary structure of the snake
venom L-amino acid oxidase shows high homology with
the mouse B cell interleukin 4-induced Fig 1 protein.
Biochem Biophys Res Comm 1998; 248: 476-478.
19. Raibekas AA, Massey V. Glycerol-induced development
of catalytically active conformation of Crotalus adamanteus
L-amino acid oxidase in vitro. Proc Natl Acad Sci USA
1996; 93: 7546-7551.
20. Torii S, Yamane K, Mashima T, Haga N, Yamamoto K,
Fox JW, Naito M, Tsuruo T. Molecular cloning and
functional analysis of apoxin I, a snake venom-derived
apoptosis-inducing factor with L-amino acid oxidase
activity. Biochemistry 2000; 39: 3197-3205.
21. Macheroux R, Seth O, Bollschweiler C, Schwarz M,
Kurfurst M, Au LC, Ghisla S. L-Amino acid oxidase from
the Malayan pit viper Calloselasma rhodostoma:
Comparative sequence analysis and characterization of
active and inactive forms of the enzyme. Eur J Biochem
2001; 268: 1679-1686.
22. Takatsuka H, Sakurai Y, Yoshioka A, Kokubo T, Usami Y,
Suzuki M, Matsui T, Titani K, Yagi H, Matsumoto M,
Fujimura Y. Molecular characterization of L-amino acid
oxidase from Agkistrodon halys blomhoffii with special
reference to platelet aggregation. Biochim Biophys Acta
2001; 1544: 267-277.
23. Zhang YI, Wang JH, Lee WH, Wang Q, Liu H, Zheng YT,
Zhang Y. Molecular characterization of Trimeresurus
stejnegeri venom L-amino acid oxidase with potential anti-
HIV activity. Biochim Biophys Res Commum 2003; 309:
598-604.
24. Kommoju PR, Macheroux P, Ghisla S. Molecular cloning,
expression and purification of L-amino acid oxidase from
Malayan pit viper Calloselasma rhodostoma. Protein Expr
Purif 2007; 52: 89-95.
25. Franca SC, Kashima S, Roberto PG, Marins M, Ticli FK,
Pereira JO, Astolfi-Filho S, Stabeli RG, Magro AJ, Fontes
MRM, Sampaio SV, Soares AM. Molecular approaches
for structural characterization of Bothrops L-amino acid
oxidases with antiprotozoal activity: cDNA cloning,
comparative sequence analysis, and molecular modeling.
Biochem Biophys Res Commun 2007; 355: 302-306.
26. Geyer A, Fitzpatrick TB, Pawelek PD, Kitzing K, Vrielink
A, Ghisla S, Macheroux P. Structure and characterization
of the glycan moiety of L-amino acid oxidase from the
Malayan pit viper Calloselasma rhodostoma. Eur J Biochem
2001; 268: 4044-4053.
27. Suhr SM, Kim DS. Comparison of the apoptotic pathways
induced by L-amino acid oxidase and hydrogen peroxide.
J Biochem (Tokyo) 1999; 125: 305-309.
28. Stabeli RG, Marcussi S, Carlos GB, Pietro RCLR, Selistre-
de-Araujo HS, Giglio JR, Oliveira EB, Soares AM.  Platelet
aggregation and antibacterial effects of an L-amino acid
oxidase purified from Bothrops alternatus snake venom.
Bioorg Med Chem 2004; 12: 2881-2886.
29. Izidoro LFM, Ribeiro MC, Souza GRL, Sant’Ana CD,
Hamaguchi A, Homsi-Brandeburgo MI, Goulart LR,
Beleboni RO, Nomizo A, Sampaio SV, Soares AM,
Rodrigues VM. Biochemical and functional characterization
of an L-amino acid oxidase isolated from Bothrops pirajai
snake venom. Bioorg Med Chem 2006; 14: 7034-7043.
30. Pawelek PD, Cheah J, Coulombe R, Macheroux P, Ghisla
S, Vrielink A. The structure of L-amino acid oxidase reveals
the substrate trajectory into an enantiometrically
conservative active site. EMBO J 2000; 19: 4204-4215.
31. Moustafa IM, Foster S, Lyubimov AY, Vrielink A. Crystal
structure of LAAO from Calloselasma rhodostoma with
an L-phenylalanine substrate: Insights into structure and
mechanism. J Mol Biol 2006; 364: 991-1002.
32. Souza DHF, Eugenio LM, Fletcher JE, Jiang MS, Garratt
RC, Oliva G, Selistre-de-Araujo HS. Isolation and structural
characterization of a cytotoxic L-amino acid oxidase from
10Snake venom L-amino acid oxidases
Agkistrodon contortrix laticinctus snake venom: Preliminary
crystallographic data. Arch Biochem Biophys 1999; 368:
285-290.
33. Samel M, Vija H, Ronnholm G, Sugiir J, Kalkkinen N,
Sugiir E. Isolation and characterization of an apoptotic
and platelet aggregation inhibiting L-amino acid oxidase
from Vipera berus berus (common viper) venom. Biochim
Biophys Acta 2006; 1764: 707-714.
34. Tonismagi K, Samel M, Trummal K, Ronnholm G, Sugiir
J, Kalkkinen N, Sugiir E. L-Amino acid oxidase from
Vipera lebetina venom: Isolation, characterization, effects
on platelets and bacteria. Toxicon 2006; 48: 227-237.
35. Tan NH, Saifuddin MN. Substrate specificity of king cobra
(Ophiophagus hannah) venom L-amino acid oxidase. Int J
Biochem 1991; 23: 323-327.
36. Dixon M, Kleppe K. D-Amino acid oxidase II. Specificity,
competitive inhibition and reaction sequence. Biochim
Biophys Acta 1965; 96: 368-382.
37. Fitzpatrick PF.  Carbanion versus hydride transfer
mechanisms in flavoprotein-catalyzed dehydrogenations.
Bioorg Chem 2004; 32: 125-139.
38. Tan NH, Lim KK, Jaafar MIN. An investigation into the
antigenic cross-reactivity of Ophiophagus hannah (king
cobra) venom and neurotoxin, phospholipase A2,
hemorrhagin and L-amino acid oxidase using enzyme-
linked immunosorbent assay. Toxicon 1993; 31: 865-872.
39. Stabeli RG, Magalhaes LMP, Selistre-de-Araujo HS,
Oliveira EB. Antibodies to a fragment of the Bothrops
moojeni L-amino acid oxidase cross-react with snake venom
components unrelated to the parent protein. Toxicon 2005;
46: 308-331.
40. Tan NH, Saifuddin MN. Isolation and characterization of
an unusual form of L-amino acid oxidase from king cobra
(Ophiophagus hannah) venom. Biochem Int 1989; 19:
937-944.
41. Tan NH, Choy SK. The edema-inducing activity of
Ophiophagus hannah (king cobra) venom L-amino acid
oxidase. In: Tan NH, Oo SL, Thambyrajah V, Azila N eds.
Advances in venom and toxin research. Kuala Lumpur:
Malaysian Society on Toxinology.1993; 268-273.
42. Sakurai Y, Shima M, Matsumoto T, Takatsuka H, Nishiya
K, Kasuda S, Fujimura Y, Yoshioka A. Anticoagulant
activity of M-LAO, L-amino acid oxidase purified from
Agkistrodon halys blomhoffii, through selective inhibition
of factor IX.   Biochem Biophys Acta  2003; 1649: 51-57
43. Li ZY, Yu TF, Lian EC. Purification and characterization
of L-amino acid oxidase from king cobra (Ophiophagus
hannah) venom and its effects on human platelet
aggregation. Toxicon 1994; 32: 1349-1358.
44. Ali SA, Stoeva S, Abbasi A, Alam JM, Kayed R, Faigle
M, Neumeister B, Voelter W. Isolation, structural and
functional characterization of an apoptosis-inducing L-
amino acid oxidase from leaf-nosed viper (Eristocophis
macmahoni) snake venom. Arch Biochem Biophys 2000;
384: 216-226.
45. Toyama MH, Toyama D de O, Passero LFD, Laurenti
MD, Corbett CE, Tomokane TY, Fonseca FV, Antunes E,
Joazeiro PP, Beriam LOS, Martins MAC, Monteiro HAS,
Fonteles MC.  Isolation of a new L-amino acid oxidase
from Crotalus durissus cascavella venom. Toxicon 2006;
47: 47-57.
46. Sakurai Y, Takatsuka H, Yoshioka A, Matsui T, Suzuki M,
Titani K, Fujimura Y. Inhibition of human platelet
aggregation by L-amino acid oxidase purified from Naja
naja kaouthia venom. Toxicon 2001; 39: 1827-1833.
47. Suhr SM, Kim DS. Identification of the snake venom
substance that induces apoptosis. Biochim. Biophys Res
Commun 1996; 224: 134-139.
48. Torii S, Naito M, Tsuruo T.  Apoxin I, a novel apoptosis-
inducing factor with L-amino acid oxidase activity purified
from western diamondback rattlesnake venom. J Biol Chem
1997; 272: 9539-9542.
49. Sun LK, Yoshii Y, Hyodo A, Tsurushima H, Saito A,
Harakuni T, Li YP, Kariya K, Nozaki M,  Morine  N.
Apoptotic effect in the glioma cells induced by specific
protein extracted from Okinawa Habu (Trimeresurus
flavoviridis) venom in relation to oxidative stress.
Toxicology in Vitro 2003; 17: 169-177.
50. Ande SR, Kommoju PR, Draxyl S, Murkovic M,
Macheroux P, Ghisla S, Ferrando-May E. Mechanisms of
cell death induction by L-amino acid oxidase, a major
component of ophidian venom. Apoptosis 2006; 11: 1439-
1451.
51. Stiles BG, Sexton FW, Weinstein SA. Antibacterial effect
in different snake venoms: purification and characterization
of antibacterial protein from Pseudochis australis
(Australian king or mulga snake) venom. Toxicon 1991;
29: 1129-1141.
52. Tempone AG, Andrade HF, Jr,  Spencer PJ, Lourenco CO,
Rogero JR, Nascimento N. Bothrops moojeni venom kills
Leishmania spp. with hydrogen peroxide generated by its
L-amino acid oxidase. Biochem Biophys Res Comm 2001;
280: 620-624.
53. Zhang H, Yang Q, Sun M, Teng M, Niu L. Hydrogen
peroxide produced by two amino acid oxidases mediates
antibacterial actions. J Microbiol 2004; 42: 336-339.
54. Tan NH,  Swaminathan S. Purification and properties of
the L-amino acid oxidase from monocellate cobra (Naja
naja kaouthia) venom. Int J Biochem 1992; 24: 967-973.
55. Abe Y, Shimoyama Y, Munakata H, Ito J, Nagata N, Obtsuki
K. Characterization of an apoptosis-inducing factor in Habu
snake venom as a glycyrrihizin (GL)-binding protein
potently inhibited by GL in vitro. Biol Pharm Bull 1998;
21: 924-927.
56. Ueda M, Chang CC, Ohno M. Purification and
characterization of L-amino acid oxidase from the venom
of Trimeresurus mucrosquamatus (Taiwan habu snake).
Toxicon  1988; 26: 695-706.
